Gastric Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 7, 2006; 12(25): 3970-3976
Published online Jul 7, 2006. doi: 10.3748/wjg.v12.i25.3970
Table 1 Correlation of uPA mRNA, uPAR mRNA and VEGF expression and clinicopathologic parameters in gastric cancer
Clinicopathologic parametersnuPA mRNA
uPAR mRNA
VEGF
-++++++-++++++-++++++
Growth pattern
Expansive4829838218811246810
Infiltrative571581123b1471719a1451325a
Invasive depth
T1-T2442792620116731553
T3-T4611771225b1541923b761632b
Vessel invasion
Absent29168231482525310
Present762881228b2172325b1382035b
Lymph node metastasis
Absent35218331782827512
Present70238112818723221162033b
Distant metastasis
Absent6339161729148123610107
Peritoneum metastasis24201111b201111b00915b
Liver metastasis1830213416721213